Skip to main content
    J

    Jazz Pharmaceuticals PLC (JAZZ)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $239.77
    -1.78 (-0.74%)

    Market Cap: $15.50B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Jazz Pharmaceuticals PLC (JAZZ) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Jazz Pharmaceuticals are Ascendis Pharma AS (ASND), Halozyme Therapeutics (HALO) and Rhythm Pharmaceuticals (RYTM). Jazz Pharmaceuticals trades at 18.4x earnings, against a median of 18.5x for the 4 of these companies with a P/E. By market cap, Jazz Pharmaceuticals ranks 5th of the 13 companies on this page; Royalty Pharma Plc (RPRX) is the largest at $39.85B.

    Peer Comparison

    JAZZ's ROIC of 3.5% is above the peer median of -2.6%, and its revenue growth of 10.4% is below the median of 55.4%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Jazz Pharmaceuticals (JAZZ)$15.50B18.4x3.3x4.4%3.5%10.4%0.00%
    Ascendis Pharma AS (ASND)$18.06BN/A13.5x72.9%12.4%73.0%0.00%
    Halozyme Therapeutics Inc (HALO)$11.43B17.8x6.1x26.9%15.8%39.2%0.00%
    Rhythm Pharmaceuticals Inc (RYTM)$7.97BN/A26.4x-69.0%-98.6%79.6%0.00%
    Summit Therapeutics PLC (SMMT)$11.32BN/AN/A0.0%N/A-100.0%0.00%
    BridgeBio Pharma Inc (BBIO)$15.25BN/A16.0x-59.8%-33.0%192.6%0.00%
    Praxis Precision Medicines Inc (PRAX)$9.17BN/AN/A0.0%N/A1349.0%0.00%
    Madrigal Pharmaceuticals Inc (MDGL)$9.93BN/A8.7x-10.9%-12.7%50.1%0.00%
    TG Therapeutics Inc (TGTX)$9.75B87.2x11.1x11.8%11.0%60.7%0.00%
    Spyre Therapeutics Inc. (SYRE)$9.88BN/AN/A0.0%N/A0.0%0.00%
    Exelixis Inc (EXEL)$16.84B19.3x6.9x35.4%N/A10.2%0.00%
    Insmed Inc (INSM)$26.58BN/A17.7x-39.9%-44.2%268.4%0.00%
    Royalty Pharma Plc (RPRX)$39.85B12.9x11.7x25.7%7.6%13.3%1.37%
    Peer median$11.37B18.5x11.7x0.0%-2.6%55.4%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Jazz Pharmaceuticals, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Ascendis Pharma AS (ASND)
    Ascendis Pharma A / S, a biopharmaceutical company, develops therapies for unmet medical needs. The company is headquartered in Hellerup, Denmark.
    ASND competitors
    Halozyme Therapeutics Inc (HALO)
    Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally.
    HALO competitors
    Rhythm Pharmaceuticals Inc (RYTM)
    Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment...
    RYTM competitors
    Summit Therapeutics PLC (SMMT)
    Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and markets drugs to treat infectious diseases in the United States, Latin America...
    SMMT competitors
    BridgeBio Pharma Inc (BBIO)
    BridgeBio Pharma, Inc. is dedicated to the discovery, development and supply of various drugs for genetic diseases.
    BBIO competitors
    Praxis Precision Medicines Inc (PRAX)
    Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal...
    PRAX competitors
    Madrigal Pharmaceuticals Inc (MDGL)
    Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates...
    MDGL competitors
    TG Therapeutics Inc (TGTX)
    TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development...
    TGTX competitors
    Spyre Therapeutics Inc. (SYRE)
    Spyre Therapeutics, Inc., a biotechnology company, focuses on advancing a pipeline of antibody therapeutics for the treatment of inflammatory bowel disease by...
    SYRE competitors
    Exelixis Inc (EXEL)
    Exelixis, Inc., an oncology-focused biotechnology company, is focused on the discovery, development...
    EXEL competitors
    Insmed Inc (INSM)
    Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases.
    INSM competitors
    Royalty Pharma Plc (RPRX)
    Royalty Pharma plc is a buyer of biopharmaceutical royalties and funder of innovations in the biopharmaceutical industry in the United States.
    RPRX competitors

    Frequently Asked Questions About JAZZ

    Who are Jazz Pharmaceuticals' main competitors?

    The companies most similar to Jazz Pharmaceuticals include Ascendis Pharma AS (ASND), Halozyme Therapeutics (HALO), Rhythm Pharmaceuticals (RYTM), Summit Therapeutics (SMMT) and BridgeBio Pharma (BBIO), listed from the closest match.

    Who is Jazz Pharmaceuticals' biggest competitor?

    Royalty Pharma Plc (RPRX) is the largest of the similar companies at $39.85B; Ascendis Pharma AS (ASND) is the closest match by business profile, size, sector and industry.

    How does JAZZ stock compare with its competitors?

    JAZZ's P/E is 18.4x against a peer median of 18.5x; its P/S is 3.3x against a peer median of 11.7x; its net margin is 4.4% against a peer median of 0.0%.

    Which of Jazz Pharmaceuticals' competitors pays a higher dividend?

    Jazz Pharmaceuticals pays no dividend. Royalty Pharma Plc (RPRX) has a higher forward dividend yield; Royalty Pharma Plc (RPRX) has the highest at 1.37%.

    Is Jazz Pharmaceuticals bigger than its competitors?

    No. Jazz Pharmaceuticals is 5th by market cap among the 13 companies on this page; the largest is Royalty Pharma Plc (RPRX) at $39.85B.